Stock Updates

How has Merck & Co. Inc.:(NYSE:MRK) performed recently?

Merck & Co. Inc. (NYSE: MRK) is a large market cap stock with a market cap of 160892. It is in the Drug Manufacturers – Major industry and sector Healthcare, with a current P/E of 35.47, a forward P/E of 15.43 and EPS of 1.64. At a stock price of 58 (0.10%) it has a dividend yield of 3.17%.

EPS growth for the last five years have been 41.50%, more recently this last year it has grown by -61.60%. The next year growth is going to be about 1.13% and more long-term 3.35% after five years. EPS growth quarter over quarter is 20.60%. Sales growth for the past five years have been -3.00% and sales growth quarter over quarter is -1.20%.

For performance, Merck & Co. Inc. the past week has seen a gain of 4.86%. For the last month performance for Merck & Co. Inc. is 3.24%. While the last quarter is 7.81% and half year, 12.40%. Finally for the year, performance is 4.27%.

The 52-week high for Merck & Co. Inc., is at -0.10%, and for the 52-week low it comes to a value of 31.34%. The 20-day simple moving average is 4.41% and 10.63% for the 200-day simple moving average.

Volatility for the week is at 1.23%, and for the month it is 1.41%. Merck & Co. Inc., has a target price of 61.45.

In terms of debt, long term debt/equity is 0.54, and for total debt/equity Merck & Co. Inc. has 0.59. The gross margin is 62.80%, while operating margin is 18.20%, the profit margin is 11.70%. The current ratio is 1.6 and the quick ratio is 1.3.

Insider ownership is at 0.04%, with instituitional ownership at 74.90%. Merck & Co. Inc. has a payout ratio of 110.40%. With the total shares outstanding coming to 2774. The shares float is 2766.95, with the float short at 1.12%, with short ratio coming to 3.5.

In terms of returns, the return on assets see Merck & Co. Inc., get 4.60%, with its returns on investment at 6.40%. Return on equity is 10.20%. So will the investors see the target price of 61.45, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Tony Dabbs

Leave a Comment